Smith Jason Drew Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$78,550.00
Insider Sells Quantity
9
Insider Sells Sum
$419,357.89

Insider Activity of Smith Jason Drew

According to the SEC Form 4 filings, Smith Jason Drew, being in a position of

  1. General Counsel at UroGen Pharma Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 8998 shares for $211,880,
    over all time since 2021-05-17, has bought 5000 shares for $78,550, and sold 50185 shares for $804,256.

Biography of Smith Jason Drew

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $211,8802100

Comparison of Insiders on Amount of Buys and Sells

2026-09-08SaleUroGen Pharma Ltd.
URGN
General Counsel
1,519
0.0029%
$42.54$64,618-7.58%
2026-02-03SaleUroGen Pharma Ltd.
URGN
General Counsel
7,479
0.0157%
$19.69$147,262+67.4%
2025-09-08SaleUroGen Pharma Ltd.
URGN
General Counsel
1,520
0.0029%
$19.11$29,047+7.98%
2025-07-28SaleUroGen Pharma Ltd.
URGN
General Counsel
7,522
0.0165%
$19.14$143,971+12.8%
2025-01-31SaleUroGen Pharma Ltd.
URGN
General Counsel
7,379
0.0172%
$11.14$82,202+54.95%
2024-09-09SaleUroGen Pharma Ltd.
URGN
General Counsel
1,521
0.0035%
$13.08$19,895-12.81%
2024-02-01SaleUroGen Pharma Ltd.
URGN
General Counsel
4,993
0.0162%
$15.78$78,790-14.81%
2024-01-31SaleUroGen Pharma Ltd.
URGN
General Counsel
4,993
0.0161%
$15.74$78,590-13.69%
2023-08-31SaleUroGen Pharma Ltd.
URGN
General Counsel
3,800
0.0129%
$18.01$68,438-16.42%
2023-01-31SaleUroGen Pharma Ltd.
URGN
General Counsel
1,636
0.0068%
$10.12$16,556+14.73%
2022-08-31SaleUroGen Pharma Ltd.
URGN
General Counsel
3,606
0.0153%
$7.21$25,999+29.66%
2022-01-31SaleUroGen Pharma Ltd.
URGN
General Counsel
414
0.0018%
$7.58$3,138+5.96%
2021-11-30SaleUroGen Pharma Ltd.
URGN
General Counsel
3,803
0.0169%
$12.03$45,750-31.97%
2021-05-17PurchaseUroGen Pharma Ltd.
URGN
General Counsel
5,000
0.022%
$15.71$78,550-10.34%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.